| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |